View More Recent Stories

Dec 14, 2021 05:00PM Ketamine One Appoints Joe Ramelli as Its New Chief Financial Officer
Dec 13, 2021 05:00PM Ketamine One Reports Audited Financial Results for the 2021 Fiscal Year
Dec 8, 2021 03:00AM KetamineOne Adds Seattle Location to US Clinical Network
Dec 2, 2021 05:00PM KetamineOne Subsidiary KGK Science Helps Client Receive New Dietary Ingredient Status from U.S. FDA
Nov 29, 2021 07:00AM Ketamine One Provides Second Update on Management Cease Trade Order
Nov 16, 2021 03:00AM Ketamine One Subsidiary IRP Health Opens Two New Veteran-Focused Clinics
Nov 15, 2021 06:00PM Ketamine One Provides Update on Management Cease Trade Order
Nov 9, 2021 05:42AM KetamineOne Capital (MEDI) Intends to Apply for a Proposed US IPO
Nov 9, 2021 03:00AM Ketamine One Announces Intention to Submit Draft Registration Statement for Proposed U.S. Initial Public Offering
Nov 4, 2021 06:00PM Ketamine One Announces Resignation of Loreto Grimaldi From Board of Directors
Nov 4, 2021 03:00AM Ketamine One Announces Virtual Mental Healthcare Platform in Partnership With iHealthOX
Nov 1, 2021 07:04PM Ketamine One Announces Late Filing of Annual Financial Statements and Management Cease Trade Order
Oct 21, 2021 06:05PM Ketamine One Provides Updated Information for Stock Exchange Listings
Oct 20, 2021 03:00AM Ketamine One Features Biostrap as Part of Inaugural Research Studies
Oct 14, 2021 03:00AM Ketamine One Launching Two Inaugural Research Studies
Oct 6, 2021 03:00AM Ketamine One Subsidiary KGK Science Contracted to Support a Ketamine Clinical Trial in the United States
Sep 24, 2021 06:00PM Ketamine One Engages Integral Wealth as Its Market-Maker
Sep 21, 2021 07:00AM Ketamine One Signs LOI with Veteran Services USA to Open Therapy Center
Sep 14, 2021 07:00AM Ketamine One Engages Psychology & Counselling Services Group for IRP Health
Sep 8, 2021 07:00AM Ketamine One Signs LOI for Two Ketamine Infusion Clinics in Texas
Sep 1, 2021 07:00AM Ketamine One to Deploy Cognetivity’s Integrated Cognitive Assessment Tool
Aug 30, 2021 07:00AM Ketamine One Subsidiary IRP Health Expands With New Veteran-Focused Clinics
Aug 23, 2021 07:00AM Ketamine One Establishes Medical Advisory Board
Aug 16, 2021 07:00AM Ketamine One Subsidiary KGK Science Secures Multiple New Contracts
Aug 4, 2021 07:00AM Ketamine One to Provide Scent-Enabled Virtual Reality Via Exclusive Agreement for Psychedelic Molecules With OVR Technology
Jul 28, 2021 07:00AM Ketamine One Advances Research Capabilities via Controlled Substance Dealers Licence Application
Jul 22, 2021 07:00AM Ketamine One’s IRP Clinic Using Innovative NeuroCatch Platform to Measure Brain Function in Injured Veterans
Jul 7, 2021 07:00AM Ketamine One Announces Adam Deffett as Interim CEO
Jun 18, 2021 06:00PM Ketamine One Engages Various Providers of Investor Relations and Media Services
Jun 17, 2021 07:00AM Ketamine One Highlights Psychedelic Research and Announces New Clinical Trial
Jun 15, 2021 06:00PM Ketamine One Closes Previously Announced Acquisition of Integrated Rehab and Performance
Jun 14, 2021 07:00AM Ketamine One Appoints Loreto Grimaldi to Board of Directors
Jun 7, 2021 06:00PM Ketamine One Enters Into Arrangement Agreement to Transfer Investments
Jun 7, 2021 06:00AM Ketamine One Launches Immersive Virtual Reality R&D Program at MindScape Clinic
Jun 3, 2021 06:24AM Ketamine One (MEDI) Signs Definitive Agreement to Acquire Integrated Rehab and Performance
Jun 3, 2021 06:00AM Ketamine One Signs Definitive Agreement to Acquire Integrated Rehab and Performance Ltd.
View More Recent Stories